TKTL2 anticorps (AA 101-200)
Aperçu rapide pour TKTL2 anticorps (AA 101-200) (ABIN6945176)
Antigène
Voir toutes TKTL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 101-200
-
Réactivité croisée
- Humain
-
Homologie
- Mouse,Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from Mouse TKTL2
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- TKTL2 (Transketolase-Like 2 (TKTL2))
-
Autre désignation
- TKTL2
-
Sujet
-
Synonyms: TKTL2, Transketolase like 2, Transketolase-like protein 2.
Background: TKTL2 plays an essential role in total transketolase activity and cell proliferation in cancer cells, after transfection with anti-TKTL1 siRNA, total transketolase activity dramatically decreases and proliferation was significantly inhibited in cancer cells. Plays a pivotal role in carcinogenesis.
-
ID gène
- 74419
-
UniProt
- Q9D4D4
Antigène
-